The ultimate objective of the Wisconsin Head and Neck SPORE Grant is to advance translational research to improve the outcome for HNC patients. HNC is the sixth most common cancer worldwide, and the US alone has over 66,000 newly diagnosed HNC patients each year. These patients frequently bear a disproportionate burden from their cancers based on the critical anatomic location of their disease. HN tumors and treatment often compromise speech, swallow and breathing function, in addition to creating significant changes in physical appearance and social interactions.
The UW SPORE Career Enhancement Pilot Program (CEP) seeks to support junior investigators, including physician scientists, to meet the challenge for innovation in methods to prevent, diagnose and advance treatment options for patients with HNC.
The UW SPORE Developmental Research Pilot Program (DRP) seeks to fund pilot project applications that will attract experienced investigators to the field of HNC, promote basic, clinical, and translational HNC research and potentially result in preliminary data to support successful competitive national grants (R01 or equivalent).
Deadlines for each:
Feb. 1 Submit LOI
Mar. 1 Submit DRP application and CEP application. These will be accessible via HN SPORE Intranet after submitting LOI.